Página Nct de ensaios clínicos
Clinical Trial Results:
Phase II study evaluating transarterial chemoembolization (TACE) in combination with sorafenib for the treatment of advanced hepatocellular carcinoma (HCC)
| Summary | |
EudraCT number | 2007-000730-40 |
Trial protocol | DE |
Global completion date | 15 Sep 2010 |
| Paediatric regulatory details | |
Is the trial part of an agreed EMA paediatric investigation plan? | No |
Is the trial in scope of article 45 of Regulation (EC) No 1901/2006? | No |
Is the trial in scope of article 46 of Regulation (EC) No 1901/2006? | No |
| Results information | |
Results version number | v1(current) |
This version publication date | 05 Feb 2020 |
First version publication date | 05 Feb 2020 |
Other versions | |
Summary report(s) | FinalReportSynopsis_Socrates_06102013 |
Note: The legislation allows summary attachments to be posted instead of the full dataset for this trial. Refer to Commission Guideline 2012/C 302/03 for further information.